Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STOP-ASM: Outcomes After Planned Discontinuation of AntiSeizure Medication
NCT07750496Phase 4Recruiting
- Sponsor
- University of Michigan
- Start
- Aug 2026
- Primary completion
- Aug 2029
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial in epilepsy, sponsored by University of Michigan. Primary endpoints: Number of patients recruited per year at 1 year, Number of planned study visits attended per patient within 1 year and 2 more. Started Aug 2026; status: recruiting.
02
Conditions
epilepsy
Beyond the preview
Go deeper on NCT07750496.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07750496.